Impact of bone marrow minimal residual disease status on quality of organ response in systemic AL amyloidosis.

Chakraborty, Rajshekhar; Hopson, Madeleine; Bhutani, Divaya; Vlad, George; Maurer, Mathew S; Griffin, Jan M; Mapara, Markus Y; Radhakrishnan, Jai; Lentzsch, Suzanne

Chakraborty, Rajshekhar; Hopson, Madeleine; Bhutani, Divaya; Vlad, George; Maurer, Mathew S; Griffin, Jan M; Mapara, Markus Y; Radhakrishnan, Jai; Lentzsch, Suzanne.

Afiliação

Chakraborty R; Department of Medicine, Columbia University Irving Medical Center, New York, New York, USA.
Hopson M; Department of Medicine, Columbia University Irving Medical Center, New York, New York, USA.
Bhutani D; Department of Medicine, Columbia University Irving Medical Center, New York, New York, USA.
Vlad G; Department of Medicine, Columbia University Irving Medical Center, New York, New York, USA.
Maurer MS; Department of Medicine, Columbia University Irving Medical Center, New York, New York, USA.
Griffin JM; Department of Medicine, Columbia University Irving Medical Center, New York, New York, USA.
Mapara MY; Department of Medicine, Columbia University Irving Medical Center, New York, New York, USA.
Radhakrishnan J; Department of Medicine, Columbia University Irving Medical Center, New York, New York, USA.
Lentzsch S; Department of Medicine, Columbia University Irving Medical Center, New York, New York, USA.

Am J Hematol ; 97(7): E244-E246, 2022 07.

Article em En | MEDLINE | ID: mdl-35385144

Assuntos

Amiloidose; Amiloidose de Cadeia Leve de Imunoglobulina; Medula Óssea; Humanos; Neoplasia Residual

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Amiloidose de Cadeia Leve de Imunoglobulina / Amiloidose Limite: Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google